Phase II trial of imatinib mesylate (STI-571) in metastatic melanoma (MM)

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 7528-7528 ◽  
Author(s):  
O. Eton ◽  
L. Billings ◽  
K. Kim ◽  
V. Prieto ◽  
D. Davis ◽  
...  
Keyword(s):  
Metastatic Melanoma ◽  
Imatinib Mesylate ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Sti 571

Phase II trial of imatinib mesylate (STI-571) in metastatic melanoma (MM)

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 7528-7528 ◽  
Author(s):  
O. Eton ◽  
L. Billings ◽  
K. Kim ◽  
V. Prieto ◽  
D. Davis ◽  
...  
Keyword(s):  
Metastatic Melanoma ◽  
Imatinib Mesylate ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Sti 571

Multicenter Phase II trial of high-dose imatinib mesylate in metastatic melanoma

Cancer ◽  
2006 ◽  
Vol 106 (9) ◽  
pp. 2005-2011 ◽  
Author(s):  
Ken Wyman ◽  
Michael B. Atkins ◽  
Victor Prieto ◽  
Omar Eton ◽  
David F. McDermott ◽  
...  
Keyword(s):  
Metastatic Melanoma ◽  
Imatinib Mesylate ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
High Dose ◽  
Multicenter Phase

scholarly journals Phase II trial of imatinib mesylate in patients with metastatic melanoma

2008 ◽  
Vol 99 (5) ◽  
pp. 734-740 ◽  
Author(s):  
K B Kim ◽  
O Eton ◽  
D W Davis ◽  
M L Frazier ◽  
D J McConkey ◽  
...  
Keyword(s):  
Metastatic Melanoma ◽  
Imatinib Mesylate ◽  
Phase Ii ◽  
Phase Ii Trial

scholarly journals A Phase II Trial of Sorafenib in Metastatic Melanoma with Tissue Correlates

PLoS ONE ◽  
2010 ◽  
Vol 5 (12) ◽  
pp. e15588 ◽  
Author(s):  
Patrick A. Ott ◽  
Anne Hamilton ◽  
Christina Min ◽  
Sara Safarzadeh-Amiri ◽  
Lauren Goldberg ◽  
...  
Keyword(s):  
Metastatic Melanoma ◽  
Phase Ii ◽  
Phase Ii Trial

A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma

2010 ◽  
Vol 30 (1) ◽  
pp. 341-349 ◽  
Author(s):  
Simon Pacey ◽  
Martin Gore ◽  
David Chao ◽  
Udai Banerji ◽  
James Larkin ◽  
...  
Keyword(s):  
Metastatic Melanoma ◽  
Phase Ii ◽  
Phase Ii Trial

A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: The AFR-15 trial

2009 ◽  
Vol 33 (8) ◽  
pp. 1124-1126 ◽  
Author(s):  
Patrice Chevallier ◽  
Mathilde Hunault-Berger ◽  
Fabrice Larosa ◽  
Charles Dauriac ◽  
Richard Garand ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Imatinib Mesylate ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
High Dose ◽  
Acute Myeloid

scholarly journals Phase II trial of biochemotherapy with interferon α, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial

1999 ◽  
Vol 125 (5) ◽  
pp. 292-296 ◽  
Author(s):  
Kim A. Margolin ◽  
P. Y. Liu ◽  
Joseph M. Unger ◽  
William S. Fletcher ◽  
Lawrence E. Flaherty ◽  
...  
Keyword(s):  
Metastatic Melanoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Interferon Α ◽  
Oncology Group ◽  
Southwest Oncology Group ◽  
Group Trial
Sign in / Sign up

Export Citation Format

Share Document